A significant decrease in these cell signaling markers were observed following BMP-7 treatment, suggesting the efficacy of BMP-7 in attenuating hypercholesterolemia-induced TGF-β1, Smad2, and Smad3 proteins. The gene discussed is SMAD2; the disease is familial hypercholesterolemia.